Estimating Progression Rates Across the Spectrum of Alzheimer’s Disease for Amyloid-Positive Individuals Using National Alzheimer’s Coordinating Center Data

Michele Potashman; Marric Buessing; Mihaela Levitchi Benea; Jeffrey L. Cummings; Soo Borson; Peter Pemberton‐Ross; Andrew J. Epstein

doi:10.1007/s40120-021-00272-1

August 24, 2021Neurology and TherapyOpen Access

Estimating Progression Rates Across the Spectrum of Alzheimer’s Disease for Amyloid-Positive Individuals Using National Alzheimer’s Coordinating Center Data

View Full Paper

Ask AI

Bookmark

Share

Abstract

These transition probabilities reflect the full continuum of AD progression in Aβ+ individuals and can be used to assess the impact of treatment on expected transitions.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Potashman et al. (2021) studied this question.

synapsesocial.com/papers/69d84b69f4e559c61eae3593 https://doi.org/10.1007/s40120-021-00272-1

View Full Paper

Ask AI

Bookmark

Share

Estimating Progression Rates Across the Spectrum of Alzheimer’s Disease for Amyloid-Positive Individuals Using National Alzheimer’s Coordinating Center Data

Abstract

Discussion

Cite This Study

Estimating Progression Rates Across the Spectrum of Alzheimer’s Disease for Amyloid-Positive Individuals Using National Alzheimer’s Coordinating Center Data

Abstract

Discussion

Cite This Study

Keep reading

More related papers

More from Neurology and Therapy

Keep reading

More related papers

More from Neurology and Therapy